surpass tirzepatide Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial 💡 New insight in diabetes

The reviews are driven by placebo effect and lifestyle changes, not pharmacology

Studies show that raising glutathione levels may help regulate immune function, reduce inflammation, and ease disease severity in conditions like lupus and rheumatoid arthritis

This synthetic tetrapeptide has become one of the most talked-about compounds in anti-aging science and for good reason

Some pharmacists struggle with making the card work

[29] This study also found similar increases in serum GLP-1 200mg/day Eriomin was found to increase it by 17%

Gallbladder Disease and Surgical Complications Novo Nordisk added gallbladder disease warnings to Ozempic labels in March 2022, but only after thousands of patients had already developed acute cholecystitis, gallstones, and other biliary complications requiring emergency surgery raising questions about what the company knew and when